SAN FRANCISCO, May 25, 2007 (PRIME NEWSWIRE) -- With nearly $2.9 billion directed to U.S. health care start-ups in just the first quarter of this year, the industry is witnessing a resurgence of attention from investors. Identifying the latest innovations and analyzing the opportunities and challenges facing this market will be highlighted at the third annual Health Care Innovations conference, produced by Dow Jones VentureWire.
The event, June 19 and 20 at the Sofitel San Francisco Bay in Redwood City, will bring together more than 50 start-up companies plus leading venture capital investors and executives from top health care and pharmaceutical corporations, to provide an in-depth look at the kinds of medical innovations being financed and the strategies necessary to navigate such start-ups from discovery through development to trials and liquidity.
Among the featured keynote interviews:
* Dr. Randall Lutter, deputy commissioner for policy and planning at the U.S. Food & Drug Administration, on the agency's direction in regards to drug safety and in improving the efficiency of the drug approval process. * Jeff Davis, head of global new business development for Procter & Gamble Pharmaceuticals, and Anthony Rosenberg, global head of business development and licensing at Novartis. They are featured in a joint interview with VentureWire Lifescience's Brian Gormley on their work collaborating with start-ups to identify the next blockbuster pharmaceuticals. * Joseph Miletich, senior vice president of research and development at Amgen. He'll be interviewed by The Wall Street Journal medical reporter Marilyn Chase on his work deploying a $3 billion research budget to discover and acquire the next blockbuster pharmaceutical. * Walter Moos, vice president of the biosciences division at SRI International, will be on hand to discuss the innovations sparked by his division as well as answer questions on the drug discovery and partnership process for SRI.
Attendees will also gain insight from numerous panel discussions including the proper capital model for life sciences companies, the exit route for health care start-ups and whether investors will find success in backing companies in China and India.
Sponsors of Health Care Innovations include Procter & Gamble, Capitol Health and Orrick. For more information or to register, please call (866) 291-1800 or go to: http://healthcare.dowjones.com/
Dow Jones & Company (NYSE:DJ) (dowjones.com) is a leading provider of global business news and information services. Its Consumer Media Group publishes The Wall Street Journal, Barron's, MarketWatch and the Far Eastern Economic Review. Its Enterprise Media Group includes Dow Jones Newswires, Factiva, Dow Jones Licensing Services, Dow Jones Indexes and Dow Jones Financial Information Services. Its Local Media Group operates community-based information franchises. Dow Jones provides news content to CNBC and radio stations in the U.S.